TITLE

Barriers to optimal treatment

PUB. DATE
February 2011
SOURCE
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p38
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the findings of a survey commissioned by Matrixx Initiatives Inc. which revealed that 92 percent of patients harbor misconceptions about colds in the U.S.
ACCESSION #
59994604

 

Related Articles

  • Zicam Line Said to Represent Next Generation of Remedies.  // MMR;2/21/2011, Vol. 28 Issue 4, p32 

    The article offers brief information on Matrixx Initiatives Inc.'s Zicam Cold Remedy Plus line.

  • NARB Finds Zicam Claims Aren't Misleading.  // Nutraceuticals World;Oct2013, Vol. 16 Issue 8, p23 

    The articel reports on a finding by the National Advertising Review Board (NARB) in New York that Matrixx Initiatives Inc,'s claims for its Zicam Cold Remedy products to prevent cold are true and not misleading.

  • Early treatment emphasized.  // Chain Drug Review;3/1/2010, Vol. 32 Issue 5, p22 

    The article reports on a survey titled National Pharmacist O.T.C. (Observations on the Treatment of Colds) sponsored by Matrixx Initiatives Inc. according to which pharmacists emphasize early treatment for cold.

  • Nutrition 21 Signs Coldizin Licensing Pact With Provita.  // Chain Drug Review;12/6/2010, Vol. 32 Issue 21, p80 

    The article offers updates on business deals of different drug industries including an agreement with Provita Development ApS of Denmark by Nutrition 21 Inc. that allows the company an exclusive license for Coldizin, a partnership between Dr. Andrea Pennington and Matrixx Initiatives Inc. to...

  • Zicam Kids Hits Store Shelves.  // MMR;12/15/2014, Vol. 31 Issue 19, p22 

    The article evaluates cold relief product Zicam Kids by healthcare company Matrixx Initiatives.

  • Q & A the cold-flu Matrixx. MARINI, JIM // Drug Store News;12/14/2009, Vol. 31 Issue 15, p69 

    An interview with Jim Marini, Vice President (VP) sales for Matrixx Initiatives Inc. is presented. When asked about the sale of cough-cold inventories in 2009-2010, he said that the H1N1 media attention increased overall consumer awareness of the cold-flu season enhancing the significance of the...

  • NAD Review Suggests Zicam Suspend Cold Prevention Claims.  // Nutraceuticals World;May2013, Vol. 16 Issue 4, p20 

    The article reports on the review of the homeopathic Zicam Cold Remedy products from Matrixx Initiatives Inc. conducted by the National Advertising Division (NAD) which recommends suspension of the advertising claims in the U.S.

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;1/5/2013, Issue 1433, p2 

    This section offers news briefs on product recalls in the pharmaceutical sector including Hospira's carboplatin, Zicam Extreme Congestion Relief nasal gel from Matrixx Initiatives and Bronkaid Dual Action Formula from Bayer Consumer Care.

  • Matrix denies liability claims against Zicam.  // Drug Store News;3/1/2004, Vol. 26 Issue 3, p32 

    Reports that Matrixx Initiatives has denied liability claims against its Zicam Cold Remedy zinc nasal gels. Complaints that the product caused anosmia.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics